The potential blunting effect of metformin and/or statin therapy on physical activity-induced associations with HbA1c in type 2 diabetes

被引：0
作者：
Henson, Joseph [1 ,2 ,8 ]
Davies, Melanie J. [1 ,2 ]
Brady, Emer M. [3 ]
Edwardson, Charlotte L. [1 ,2 ]
Hall, Andrew P. [4 ]
Khunti, Kamlesh [2 ,5 ]
Redman, Emma [6 ]
Rowlands, Alex V. [1 ,2 ,7 ]
Sargeant, Jack [1 ,2 ,6 ]
Yates, Thomas [1 ,2 ]
机构：
[1] Leicester Biomed Res Ctr, NIHR, Leicester, England
[2] Univ Leicester, Coll Life Sci, Diabet Res Ctr, Leicester, England
[3] Univ Leicester, Dept Cardiovasc Sci, Leicester, England
[4] Leicester Gen Hosp, Hanning Sleep Lab, Leicester, England
[5] Leicester Diabet Ctr, Appl Hlth Res Collaborat East Midlands NIHR ARC EM, NIHR, Leicester, England
[6] Univ Hosp Leicester NHS Trust, Leicester Diabet Ctr, Leicester, England
[7] Univ South Australia, Alliance Res Exercise, Nutr & Act ARENA, UniSA Allied Hlth & Human Performance, Adelaide, SA, Australia
[8] Leicester Diabet Ctr, Leicester LE5 4PW, England
来源：
JOURNAL OF DIABETES | 2024年 / 16卷 / 02期
关键词：
metformin; physical activity; statins; type; 2; diabetes; EXERCISE;
D O I：
10.1111/1753-0407.13495
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [31] The Associations of Mean Glucose and Time in Range from Continuous Glucose Monitoring with HbA1c in Adults with Type 2 Diabetes
    Selvin, Elizabeth
    Wang, Dan
    Rooney, Mary R.
    Echouffo-Tcheugui, Justin
    Fang, Michael
    Zeger, Scott
    Sartini, Joseph
    Tang, Olive
    Coresh, Josef
    Aurora, R. Nisha
    Punjabi, Naresh M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 (01) : 86 - 90
  • [32] Associations between clinical and psychosocial factors and HbA1c in adult insulin pump users with type 1 diabetes
    Schmidt, Signe
    Madsen, Kristoffer Panduro
    Pedersen-Bjergaard, Ulrik
    Rytter, Karen
    Hommel, Eva
    Cleal, Bryan
    Willaing, Ingrid
    Andersen, Henrik Ullits
    Norgaard, Kirsten
    ACTA DIABETOLOGICA, 2023, 60 (08) : 1089 - 1097
  • [33] Associations between HbA1c and depressive symptoms in young adults with early-onset type 1 diabetes
    Baechle, Christina
    Lange, Karin
    Stahl-Pehe, Anna
    Castillo, Katty
    Holl, Reinhard W.
    Giani, Guido
    Rosenbauer, Joachim
    PSYCHONEUROENDOCRINOLOGY, 2015, 55 : 48 - 58
  • [34] Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes
    Inzucchi, Silvio E.
    Davies, Melanie J.
    Khunti, Kamlesh
    Trivedi, Prabhav
    George, Jyothis T.
    Zwiener, Isabella
    Johansen, Odd Erik
    Sattar, Naveed
    DIABETES OBESITY & METABOLISM, 2021, 23 (02) : 425 - 433
  • [35] Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
    Sun, Bao
    Gao, Yongchao
    He, Fazhong
    Liu, Zhaoqian
    Zhou, Jiecan
    Wang, Xingyu
    Zhang, Wei
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [36] Baseline HbA1c predicts attainment of 7.0% HbA1c target with structured titration of insulin glargine in type 2 diabetes: a patient-level analysis of 12 studies
    Riddle, M. C.
    Vlajnic, A.
    Zhou, R.
    Rosenstock, J.
    DIABETES OBESITY & METABOLISM, 2013, 15 (09) : 819 - 825
  • [37] Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline
    McGill, Janet B.
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George L.
    Filippatos, Gerasimos
    Pitt, Bertram
    Ruilope, Luis M.
    Birkenfeld, Andreas L.
    Caramori, Maria L.
    Brinker, Meike
    Joseph, Amer
    Lage, Andrea
    Lawatscheck, Robert
    Scott, Charlie
    Rossing, Peter
    FIDELIO-DKD Investigator
    FIGARO-DKD Investigator
    DIABETES OBESITY & METABOLISM, 2023, 25 (06) : 1512 - 1522
  • [38] Comparison between vildagliptin and metformin to sustain reductions in HbA1c over 1 year in drug-naive patients with Type 2 diabetes
    Schweizer, A.
    Couturier, A.
    Foley, J. E.
    Dejager, S.
    DIABETIC MEDICINE, 2007, 24 (09) : 955 - 961
  • [39] Drug titration patterns and HbA1c levels in type 2 diabetes
    Maclean, J. Ross
    Chapman, R. H.
    Ferrufino, C. P.
    Krishnarajah, G.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2009, 63 (07) : 1008 - 1016
  • [40] Impact of postprandial and fasting glucose concentrations on HbA1c in patients with type 2 diabetes
    Schernthaner, G.
    Guerci, B.
    Gallwitz, B.
    Rose, L.
    Nicolay, C.
    Kraus, P.
    Kazda, C.
    DIABETES & METABOLISM, 2010, 36 (05) : 389 - 394
12345